Our 2023 conference starts with an exclusive interview with senior industry leaders Susan Rienow Country President UK, Pfizer and President, ABPI, Marie-Andreé Gamache Country President, Novartis UK and Ireland and Dr Antonio Payano CEO, Bayer UK and Ireland.  

 

They will address questions around revolutionary digital innovations and the UK’s role in supporting pharma innovation, in a conversation led by Tamsin Berry, Head of Policy and Partnerships at AreteiaTx, and Partner at Population Health Partners.

 

 

 

• Tackling health challenges, such as chronic conditions, respiratory disease, and cancer

 

• The use of technology to improve health outcomes, improve sustainability and create robust supply chains

 

• Enabling a better industry, through the creation of diverse, skilled teams, empowering the patient and navigating the economic and regulatory environment.

 

 

 

Eleven lively panel sessions will include discussion around: 

 

• Trialling a new approach to clinical trials, facilitated by one of the UK’s leading policy advisors, Lord James O’Shaughnessy

 

• Evolution of distribution models, as companies embrace new tech to streamline supply chains – led by Stef Kulik who is helping put Royal Mail at the forefront of improving healthcare for communities across the UK 

 

• Moving from a ‘sick care’ service, to a ‘health care’ service and how a focus on preventative healthcare can support a healthier and wealthier nation, facilitated by John Deanfield, CBE 

 

• New model of the mega CDMO and resultant changes to the contract manufacturing landscape, facilitated by Brennan Miles, Head of Drug Delivery at Team Consulting.

 

“Pharma Integrates is the highlight of our event programme and always attracts key players across pharma & healthcare. Delegates and speakers are keen to connect with peers, discuss how to overcome market challenges and generate new thinking that will, ultimately, lead to improvements in the delivery of healthcare, and patient outcomes” said Christopher Watt, Executive Director, Life Science Integrates.

 

 

“The calibre of speakers, this year, is as high as ever, reflecting the value of Pharma Integrates to senior leaders across the healthcare spectrum. In a rapidly changing landscape, there is so much to think about, whether around drug discovery, patient access, policy changes, or clinical trials” said Samuel Thangiah, Executive Director, Life Science Integrates. “As a community, we continue to drive progressive change and Life Science Integrates plays an important role in facilitating change and innovation across the sector”.

 

 

Explore the full agenda and extensive list of speakers and ensure you register to guarantee your place.